Table 2 Molecular diagnoses reported by variant type

From: Clinical whole genome sequencing as a first-tier test at a resource-limited dysmorphology clinic in Mexico

SNVs and indels

ID

Age/gender

Family structurea

Phenotype

Genomic variant(s)

{molecular state-inheritance}

Associated condition (phenotype MIM number)

Classificationb

P1

15.5-yo/F

Proband-only

Fatigue, muscle pain, exercise intolerance, abnormal gait- walks leaning forward and drags one foot, frequent falls, asthma, short stature, ptosis, short 5th metacarpals, 5th finger clinodactyly, learning difficulties, aggressive behavior, anxiety, amenorrhea, non-specific abnormal muscle biopsy

CHRNE c.1116_1128delGTCGT

CGGTGGGC (p.Ser373TyrfsTer8) {hom-unk}

[NM_000080.3]

Congenital myasthenic syndrome

(605809); AR

LP

P2

5-yo/M

Duo

DD, severe growth restriction with microcephaly, dysmorphic facies, cortical blindness, constant movement

TSEN54 c.919G>T (p.Ala307Ser)

{hom-mat} [NM_207346.2]

Pontocerebellar hypoplasia (277470);

AR

P

P3

11-yo/F

Duo

Developmental regression, loss of language, purposeful and repetitive hand movement, scoliosis, mildly ataxic gait, self-injurious behavior

MECP2 c.916C>T p.Arg306Cys {het-unk}

[NM_004992.3]

Rett syndrome (312750); AD

P

P4

7.5-yo/M

Duo

DD including speech delay, learning and language impairment, hypotonia, camptodactyly, midface hypoplasia,

tubular nose, small mouth, secondary alveolar hyperplasia, abnormal palmar creases

NEB c.7645-1G>C {het-mat}

[NM_001271208.1]

NEB c.11628G>A (p.Trp3876Ter) {het-unk}

[NM_001271208.1]

Nemaline myopathy (256030); AR

LP

LP

P5

11.5-yo/M

Duo

DD, ID, expressive speech delay involving

regression, short stature, right unilateral

cryptorchidism, friendly demeanor with

plenty of affection, anxiety

KDM5C c.4006dupC

(p.Leu1336ProfsTer11)

{hem-DN}

[NM_004187.3]

X-linked intellectual disability

(300534); XL

LP

P6

12-yo/M

Duo

ID, dysmorphic facies, short fourth

metatarsals, obesity, and ADHD

EP300 c.2876G>T (p.Ser959Ile) {het-unk}

[NM_001429.3]

Secondary finding:

749 kb loss at 7p22.1, including at least

exons 1–10 of PMS2

(chr7:6027017-6776186)

{het-unk}

Rubinstein–Taybi syndrome

(613684); AD

Lynch syndrome (614337); AD

VUS

LP

P7

9.5-yo/M

Trio

Global DD, microcephaly, seizures,

truncal hypotonia, choreoathetoid

movements, hand-wringing behaviors,

sleep disturbance, dysmorphic facies

FOXG1 c.506delG (p.Gly169AlafsTer23)

{het-DN}

[NM_005249.4]

Rett-like syndrome (613454); AD

P

P8

5-yo/F

Trio

MRI findings of lissencephaly, agenesis of

the corpus callosum, small cerebellum

with Dandy–Walker malformation. Severe

post-natal growth restriction with

microcephaly, global DD, ASD, hearing

loss, dysmorphic facies, seizures,

scoliosis, hypertonia, spastic quadriplegia

TUBA1A c.1096G>C (p.Gly366Arg)

{het-DN}

[NM_006009.3]

Lissencephaly (611603); AD

P

P9

13-yo/F

Trio

ID, DD, hypotonia, hemivertebrae,

scoliosis, long tapered fingers, broad

thumbs, and great toes, hallux valgus,

broad columella, tooth abnormalities, and

relative prognathism

CTNNB1 c.865_869delACAAA

(p.Thr289CysfsTer2) {het-DN}

[NM_001904.3]

Syndromic intellectual disability

(615075); AD

P

P10

4.5-yo/F

Trio

DD, ID, pre- and post-natal growth

deficiency, microcephaly, microtia, atresia

of the right ear canal, Pierre-Robin

sequence with cleft palate, bilateral ear

tags, strabismus, proximal placement of

thumbs

EFTUD2 c.1904dupT (p.Tyr636LeufsTer8)

{het-DN} [NM_ 004247.3]

Mandibulofacial dysostosis-

microcephaly syndrome (610536);

AD

P

P11

7-yo/M

Trio

Short stature, severe hip dysplasia with

flattening and obliteration of the epiphysis,

a small fragmented proximal humeral

epiphysis, an increased span to height

ratio (1.06), an increased upper to lower

segment ratio (1.4), limited elbow

extension, asymmetric pectus carinatum,

lumbar lordosis, umbilical hernia, tapering

calves

COL2A1 c.3121G>A (p.Gly1041Ser) {het-

DN} [NM_001844.4]

Type II collagenopathies (120140);

AD

P

P12

4.5-yo/M

Trio

DD, FTT, microcephaly, recurrent

infections, sleep apnea, bilateral eye

abnormalities including blepharophimosis

and epicanthal folds, cup-shaped ears

with a right ear tag, smooth philtrum,

bilateral single transverse palmar creases

and hypoplastic thenar creases, diastasis

recti, hydrocele, pigmentary abnormalities

UBE3B c.518C>A (p.Ser173Ter) {het-mat}

[NM_130466.3]

UBE3B c.61G>T (p.Glu21Ter) {het-pat}

[NM_130466.3]

Secondary finding:

BRCA2 c.658_659delGT

(p.Val220IlefsTer4) {het-mat}

[NM_000059.3]

Kaufman oculocerebrofacial

syndrome (244450); AR

Hereditary breast and ovarian cancer syndrome (612555); AD

P

P

P

P13

4.5-yo/M

Trio

Striking ataxia, epilepsy, regression of

speech and motor ability with onset

around age 3

TPP1 c.379C>T (p.Arg127Ter) {het-mat}

[NM_000391.3]

TPP1 c.1496dupC (p.Leu500SerfsTer18) {het-pat}

[NM_000391.3]

Neuronal ceroid lipofuscinosis

disease (204500); AR

P

P

P14

3-yo/M

Trio

Psychomotor delay, speech delay, low

anterior hairline, minor plagiocephaly,

broad nasal tip, mild 5th finger

clinodactyly, shawl scrotum, inappropriate

laughter, wide-based gait

NAA15 c.382C>T (p.Arg128Ter) {het-DN}

[NM_057175.3]

Intellectual disability (617787); AD

P

P15

17.5-yo/M

Trio

DD, ID, growth delay, mild microcephaly,

dysmorphic facies, low hair line, short

neck, decrease elbow mobility, prominent

fetal pads, cryptorchidism, constipation

KMT2A c.3034C>T (p.Gln1012Ter) {het-

DN}

[NM_001197104.1]

Wiedemann Steiner syndrome

(605130); AD

P

P16

21.5-yo/F

Trio

ID, expressive language delay,

hydronephrosis, bilateral hip dysplasia,

septal hypertrophy and

cardiomyopathy, coarse facies, maxillary

hypoplasia, thick curly hair, hypoplastic

distal phalanges with thick knuckles and

small nails, redundant and loose skin on hands

HRAS c.34G>A (p.Gly12Ser)

{het-DN}

[NM_005343.2]

Costello syndrome (218040); AD

P

P17

1.5-yo/F

Trio

Epilepsy, appendicular hypertonia, axial

hypotonia, feeding difficulties,

constipation, short sternum, one adducted

and short thumb, clinodactyly of the

second fingers and second toes,

syndactyly on both hands, absence of

distal creases

CACNA1G c.4591A>G

(p.Met1531Val) {het-DN}

[NM_018896.4]

CACNA1G-related

Disorders (616795); AD

LP

P18

12-yo/F

Trio

Global DD with absent speech, behavioral

issues, feeding difficulties, post-natal

growth retardation with microcephaly,

seizures, ASD

SMARCA4 c.2678T>G (p.Leu893Arg)

{het-DN}

[NM_001128849.1]

Coffin-Siris syndrome (614609); AD

LP

P19

16-yo/F

Trio

ID, DD (motor and speech delay with

progressive selective mutism), self-

aggressive behavior, severe anxiety,

social avoidance, short stature, scoliosis,

high pain tolerance, dysmorphic features,

mild micrognathia, joint hypermobility,

small hands, brachydactyly with

hypoplastic distal phalanges of all fingers

and very short fourth and especially fifth

metacarpals and metatarsals.

HDAC8 c.943T>A (p.Trp315Arg) {het-DN}

[NM_018486.2]

Cornelia de Lange syndrome

(300882); XLD

LP

P20

14-yo/M

Quad (with

affected 4 yo

brother and

affected father)

Proband: Primary microcephaly, seizures,

ID, attention deficit

Affected Brother: Primary microcephaly

and seizures, ptosis, astigmatism,

nystagmus, epicanthal folds, posterior

parietal hair whorls, a large incisor,

smooth philtrum, and a single transverse

palmar crease.

Father: Microcephaly

KIF11 c.308+1G>A, {het-pat}

[NM_004523.3]

Microcephaly with or without

chorioretinopathy, lymphedema, or

intellectual disability (152950); AD

VUS

Aneuploidies and UPD

ID

Age/gender

Family structurea

Phenotype

Genomic variant(s)

Associated condition (phenotype MIM number)

Classificationb

P21

4.5-yo/F

Duo

Global DD, ataxia, dysmorphic facies,

facial asymmetry while crying, feeding

difficulties, aggressive behavior

Depth of 4× on p-arm of chr18

Tetrasomy 18p

(614290)

P

P22

1.5-yo/F

Trio

Multiple congenital anomalies,

hypomelanosis of Ito

Depth of 2.47× on chr14c

Mosaic trisomy 14

P

P23

4-yo/F

Trio

Global DD, dysmorphic facies, broad-

based ataxic gait

UPD of chr15 {pat}

Angelman syndrome

(105830)

P

CNVs and derivative chromosomes

ID

Age/gender

Family structurea

Phenotype

Genomic variant(s)

{inheritance}

Associated condition

(phenotype MIM number)

Classificationb

P24

11-yo/M

Duo

DD, ID, FTT, dysmorphic facies, cleft

palate, tapered fingers, PDA, hypoplastic

nails

6.6 Mb loss at 2q36.1-q37.3, mosaic

(chr2:236478472-243048854)d

2.7 Mb gain at 3q29, mosaic

(chr3:195106447-197846145)d

Derivative chromosome 2, including 2q37 microdeletion syndrome

P

P25

5-yo/F

Duo

DD, ID with expressive language delay, behavioral issues, joint laxity, loose skin, easy bruising, low tone, dysmorphic facies, bifid uvula, two supernumerary nipples, diastasis recti, overlapping toes, flat feet, a single transverse palmar crease, prominent finger pads on her right hand, 4th finger clinodactyly, decreased fetal movement in prenatal stage with dorsiflexion of the feet and fisted hands at birth

510.8 kb loss at 21q22.3

(chr21:47590586-48101334)

34.4 Mb gain at 3p26.3-p22.3 (chr3:60000-34461438)

Derivative chromosome 21, including partial trisomy 3p syndrome

P

P26

9.5-yo/M

Duo

Growth restriction with microcephaly, ID, absent speech, hyperactivity, dysmorphic facies, seizures

15.5 Mb loss at 6q21-22.31

(chr6:109324789-124836619)

{unk}

2.5 Mb loss at 6q22.33-23.2

(chr6:129969121-132499298)

{unk}

1.95 Mb gain at 11p15.4

(chr11:8548056-10497905)

{unk}

Acro-cardio-facial syndrome (6q21-6q22.1 deletion); complex chromosomal change

Complex chromosomal change

Complex chromosomal change

P

VUS

VUS

P27

15-yo/M

Duo

DD, ID, recurrent infections, cryptorchidism, mild hearing loss, mild autistic behavior, crowded teeth, micrognathia, second toe overlaps the first toe on both feet

3.48 Mb gain at 1q22-q23.2

(chr1:155709113-159191078)

{unk}

Disease association NOS

VUS-LP

P28

3-yo/F

Trio

DD, FTT, PDA with pulmonary hypertension, poor growth with microcephaly, dysmorphic facies, including bilateral 5th finger clinodactyly, hypoplastic nails, protuberant and anteverted ears, short and broad hands and feet, excessive sweating, feeding difficulties

3.78 Mb loss at 15q26.3

(chr15:98615561-102400033)

15.21 Mb gain at 13q32.2q34

(chr13:99892724-115108414)

Derivative chromosome 15

P

P29

9-yo/M

Trio

ID, hypotonia, growth deficiency, microcephaly with sagittal and metopic craniosynostosis, two anterior hair whorls, large malformed ears with narrow canals, dysmorphic facies, bilateral 2,3,4 campodactyly, bulbous toes, a short left fourth metatarsal, contracted knees, one kidney smaller than the other, cryptorchidism

18.3 Mb loss at 1p36.12-36.32

(chr1:4436802-22782007)

{DN}

1p36 deletion syndrome (607872)

P

P30

4.5-yo/F

Trio

ID, DD, aggressive behavior, anxiety, macrocephaly, dysmorphic facies, hypertrichosis, large hands, large ears, MRI findings of an increase in extra-axial space and dilatation of the Virchow–Robin space

2 Mb loss at 5q35.2-35.3

(chr5:175470000-177450000) {DN}

Sotos syndrome (117550)

P

P31

20-yo/M

Trio

Expressive speech delay, learning disabilities, hypertrophic cardiomyopathy, telangiectasia, facial flushing, acroparesthesia, joint pain, headaches

5.1 Mb gain at 8p23.1

(chr 8: 7153587-12245784)e

{DN}

8p23.1 duplication syndrome

P

P32

1-yo/F

Trio

​Gross motor DD, prenatal growth restriction, FTT, striking generalized hypotonia with head lag, ASD with pulmonary insufficiency, mild nasopharyngeal reflux, dysmorphic facies, bilateral shoulder dimples, small hands with prominent fetal pads, bilateral single transverse palmar creases, tapered fingers, bilateral fifth finger clinodactyly, small and puffy feet

5.76 Mb loss at 14q32.31-14qter (chr14:101522804-107289470)

{DN}

14q32.3 terminal deletion syndrome

P

P33

10.5/F

Trio

DD, ID, hypotonia, dysmorphic facies, partial 2–3 and 3–4 syndactyly of the hands, astigmatism, anterior crossbite, sleep apnea

2.4 Mb loss at 1q42.2-42.3

(chr1:234117880-236536349)

{DN}

1q4 deletion syndrome

P

P34

5.5-yo/M

Trio

DD, bilateral club feet, inguinal and umbilical hernias, aplasia cutis congenita, spina bifida occulta, dysmorphic facies, long fingers, and small patellas which are dislocated to the left

9.86 Mb loss at 5q23.2-q31.1

(chr5:124864529-134720575)

{DN}

5q22-q31 deletion syndrome

P

P35

1-yo/M

Trio

(with affected father)

FTT, dysmorphic facies, mild retrognathia, low set ears, small hands with brachydactyly, fifth finger clinodactyly, and persistent fetal pads, infantile acne, large hypopigmented spot on abdomen

2.3 Mb loss at 1q24.2-25.1

(chr1:170777501-173113232) {pat}

1q24-25 deletion syndrome

VUS-LP

P36

10-yo/M

Trio

DD, behavioral issues, feeding difficulties, hyperextensible and buckling phalanges, dysmorphic facies

26.3 kb loss at 14q32.3, mosaic

(chr6:101261679-101288013)f

{DN}

Kagami–Ogata syndrome (608149)

VUS

P37

11-yo/F

Quad

ID, microcephaly, absent speech, ataxia, aggressive and self-injurious behavior, dysmorphic facies

3.02 Mb loss at 2p25.3

(chr2:11314-3033976)

7.30 Mb gain at 16q23.3-24.3

(chr16:82865402-90163542)

Derivative chromosome 2

P

P38

1.5-yo/M

Quad

with affected maternal half-brother

ID, ASD, prominent fetal pads, long fingers, multiple ear tags, bilateral ear pits, low hairline, microcephaly, non-verbal, non-ambulatory

3.5 Mb gain at 22q11.1-q11.21 (chr22:16849364-20311389)

18.3 Mb gain at 11q23.3qter

(chr11:116684536-134945187)

Emanuel syndrome (609029)

P

Multiple variant types implicated in primary molecular diagnoses

ID

Age/gender

Family structurea

Phenotype

Genomic variant(s)

{molecular state-inheritance}

Associated condition (phenotype MIM number)

Classificationb

P39

14-yo/F

Trio

DD including cognitive deficiency and lack of speech, growth deficiency, epilepsy, behavioral issues including autism and self-injurious tendencies, lack of secondary sexual characteristics, coarse facies, long tapered

fingers, thick lips, over-folded ears, broad-based and duck-footed gait, lactose intolerance, constipation

SCN2A c.224C>G (p.Ser75Ter) {het-DN}

[NM_001040142.1]

KISS1R c.233A>G (p.Asn78Ser) {hem-mat}

[NM_032551.4]

358.7 kb loss at 19p13.3 (chr19:916637-1275315)

– Includes full-gene deletion of KISS1R and STK11

{DN}

Incidental finding:

CHEK2 c.349A>G (p.Arg117Gly)

{het-mat}

[NM_007194.3]

SCN2A-related disorders (607745); AD

Isolated GnRH Deficiency (614837); AR

Isolated GnRH Deficiency (614837); AR

and Peutz–Jeghers syndrome (175200); AD as secondary finding

CHEK2-related cancer susceptibility (609265); AD

P

VUS

P

LP

P40

1-yo/M

Trio

Joint contractures, short neck, dysmorphic facies, bilateral cryptorchidism, micrognathia, hypoplastic corpus callosum

ECEL1 c.793C>T (p.Gln265Ter) {het-pat} [NM_004826.2]

ECEL1 c.110_155delTCCCGTTGGGC

GCTGCGCGCAGCGCCACCGGGGCCCGGTCCGGGCT

(p.Phe37CysfsTer151) {het-mat}g

[NM_004826.2]

Distal arthrogryposis, type 5D (615065); AR

LP

LP

P41

9-yo/M

Trio

with mother affected with myopathy

Scapular winging, severe muscle weakness, long and myopathic facies, clinical diagnosis of Down syndrome

Mother: Muscle weakness and abnormal muscle biopsy

ACTA1 c.821C>T (p.Ala274Val)

{het-mat}

[NM_001100.3]

Depth of 3× on chr 21

Nemaline myopathy (161800); AD

Trisomy 21/Down syndrome (190685)h

LP

P

  1. M male, F female, SNV single nucleotide variant, indel insertions and deletions, UPD uniparental disomy, CNV copy number variant, P pathogenic, LP likely pathogenic, VUS variant of unknown significance, DD developmental delay, ID intellectual disability, FTT failure to thrive, PDA patent ductus arteriosus, ASD atrial septal defect, ADHD attention deficit hyperactivity disorder, AR autosomal recessive, AD autosomal dominant, XL x-linked, XLD x-linked dominant, het heterozygous, hom homozygous, hem hemizygous, mat maternal, pat paternal, unk unknown, DN de novo, NOS not otherwise specified
  2. aAll family members sequenced for family-based analysis were unaffected unless otherwise specified in the table.
  3. bClassification per ICSL laboratory interpretation, following the general framework of the ACMG Guidelines19,20
  4. cICSL cWGS purity estimate for trisomy 14 is 47%, orthogonally confirmed at 51% purity by external lab via chromosomal microarray;
  5. dICSL cWGS purity estimate for derivative chromosome 2 is 64%, orthogonally confirmed at 63% purity by external lab via chromosomal microarray
  6. eAssociated syndrome explains only part of proband’s phenotype
  7. fVariant falls outside ICSL test definition and was not confirmed by an external clinical laboratory
  8. gOrthogonally confirmed by external lab via targeted sequencing
  9. hPreviously clinically diagnosed and cytogenetically confirmed with 47, XY + 21 karyotype